Eurofins reported its Q1 17 trading update (only top-line figures provided) slightly ahead of consensus expectations. Net revenue grew organically by 7% (10% in Q1 16) with the contributions from forex (+1.6%) and acquisitions (+9%) taking reported sales growth to c.18% (€685m vs. the street’s expectation of €675.5m). The growth was broad based with all geographies trending northwards, particularly the US (c.33% revenue contribution) which grew faster than the group. Key European markets, France ....
03 May 2017
Q1 17 sales a consensus beat but valuation remains full
Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
Q1 17 sales a consensus beat but valuation remains full
Eurofins Scientific SE (ESF:WBO) | 0 0 1.6% | Mkt Cap: 8,723m
- Published:
03 May 2017 -
Author:
Jyoti Prakash -
Pages:
3
Eurofins reported its Q1 17 trading update (only top-line figures provided) slightly ahead of consensus expectations. Net revenue grew organically by 7% (10% in Q1 16) with the contributions from forex (+1.6%) and acquisitions (+9%) taking reported sales growth to c.18% (€685m vs. the street’s expectation of €675.5m). The growth was broad based with all geographies trending northwards, particularly the US (c.33% revenue contribution) which grew faster than the group. Key European markets, France ....